1. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455 (7215):894-902. doi:10.1038/nature07455
2. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nature reviews Neuroscience 7 (2):137-151. doi:10.1038/nrn1846
3. Castren E (2013) Neuronal network plasticity and recovery from depression. JAMA psychiatry 70 (9):983-989. doi:10.1001/jamapsychiatry.2013.1
4. Pan A, Sun Q, Czernichow S, Kivimaki M, Okereke OI, Lucas M, Manson JE, Ascherio A, Hu FB (2012) Bidirectional association between depression and obesity in middle-aged and older women. International journal of obesity 36 (4):595-602. doi:10.1038/ijo.2011.111
5. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes care 24 (6):1069-1078
6. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG (2010) Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Archives of general psychiatry 67 (3):220-229. doi:10.1001/archgenpsychiatry.2010.2
7. Hryhorczuk C, Sharma S, Fulton SE (2013) Metabolic disturbances connecting obesity and depression. Frontiers in neuroscience 7:177. doi:10.3389/fnins.2013.00177
8. Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, Maisano C, Jones L, Murrah NV, Vaccarino V (2008) Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biological psychiatry 64 (10):896-900. doi:10.1016/j.biopsych.2008.05.019
9. Willson TM, Lambert MH, Kliewer SA (2001) Peroxisome proliferator-activated receptor gamma and metabolic disease. Annual review of biochemistry 70:341-367. doi:10.1146/annurev.biochem.70.1.341
10. Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Bluher M, Griffin PR, Spiegelman BM (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466 (7305):451-456. doi:10.1038/nature09291
11. Ji-Rong Y, Bi-Rong D, Chang-Quan H, Zhen-Chan L, Hong-Mei W, Yan-Ling Z, Mattis TA (2009) Pro12Ala polymorphism in PPARgamma2 associated with depression in Chinese nonagenarians/centenarians. Archives of medical research 40 (5):411-415. doi:10.1016/j.arcmed.2009.05.005
12. Eissa Ahmed AA, Al-Rasheed NM, Al-Rasheed NM (2009) Antidepressant-like effects of rosiglitazone, a PPARgamma agonist, in the rat forced swim and mouse tail suspension tests. Behavioural pharmacology 20 (7):635-642. doi:10.1097/FBP.0b013e328331b9bf
13. Guo M, Li C, Lei Y, Xu S, Zhao D, Lu XY (2017) Role of the adipose PPARgamma-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors. Molecular psychiatry 22 (7):1056-1068. doi:10.1038/mp.2016.225
14. Zhou L, Yin J, Wang C, Liao J, Liu G, Chen L (2014) Lack of seipin in neurons results in anxiety- and depression-like behaviors via down regulation of PPARgamma. Human molecular genetics 23 (15):4094-4102. doi:10.1093/hmg/ddu126
15. Casanova E, Fehsenfeld S, Mantamadiotis T, Lemberger T, Greiner E, Stewart AF, Schutz G (2001) A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Genesis 31 (1):37-42. doi:10.1002/gene.1078
16. Zhao X, Strong R, Zhang J, Sun G, Tsien JZ, Cui Z, Grotta JC, Aronowski J (2009) Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. The Journal of neuroscience : the official journal of the Society for Neuroscience 29 (19):6186-6195. doi:10.1523/JNEUROSCI.5857-08.2009
17. Yang Y, Qin X, Liu S, Li J, Zhu X, Gao T, Wang X (2011) Peroxisome proliferator-activated receptor gamma is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress. Journal of neurochemistry 118 (3):429-439. doi:10.1111/j.1471-4159.2011.07316.x
18. Cao X, Li LP, Wang Q, Wu Q, Hu HH, Zhang M, Fang YY, Zhang J, Li SJ, Xiong WC, Yan HC, Gao YB, Liu JH, Li XW, Sun LR, Zeng YN, Zhu XH, Gao TM (2013) Astrocyte-derived ATP modulates depressive-like behaviors. Nature medicine 19 (6):773-777. doi:10.1038/nm.3162
19. Golden SA, Covington HE, 3rd, Berton O, Russo SJ (2011) A standardized protocol for repeated social defeat stress in mice. Nature protocols 6 (8):1183-1191. doi:10.1038/nprot.2011.361
20. Kirshenbaum GS, Saltzman K, Rose B, Petersen J, Vilsen B, Roder JC (2011) Decreased neuronal Na+, K+ -ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes, brain, and behavior 10 (5):542-550. doi:10.1111/j.1601-183X.2011.00691.x
21. Zhao Q, Wu X, Yan S, Xie X, Fan Y, Zhang J, Peng C, You Z (2016) The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARgamma-mediated alteration of microglial activation phenotypes. Journal of neuroinflammation 13 (1):259. doi:10.1186/s12974-016-0728-y
22. Liu J, Guo M, Zhang D, Cheng SY, Liu M, Ding J, Scherer PE, Liu F, Lu XY (2012) Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity. Proceedings of the National Academy of Sciences of the United States of America 109 (30):12248-12253. doi:10.1073/pnas.1202835109
23. Moreno S, Farioli-Vecchioli S, Ceru MP (2004) Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123 (1):131-145. doi:10.1016/j.neuroscience.2003.08.064
24. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131 (2):391-404. doi:10.1016/j.cell.2007.09.018
25. Eckel-Mahan KL, Patel VR, de Mateo S, Orozco-Solis R, Ceglia NJ, Sahar S, Dilag-Penilla SA, Dyar KA, Baldi P, Sassone-Corsi P (2013) Reprogramming of the circadian clock by nutritional challenge. Cell 155 (7):1464-1478. doi:10.1016/j.cell.2013.11.034
26. Kemp DE, Ismail-Beigi F, Calabrese JR (2009) Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome. The American journal of psychiatry 166 (5):619. doi:10.1176/appi.ajp.2008.08081195
27. Kemp DE, Ismail-Beigi F, Ganocy SJ, Conroy C, Gao K, Obral S, Fein E, Findling RL, Calabrese JR (2012) Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. Journal of affective disorders 136 (3):1164-1173. doi:10.1016/j.jad.2011.06.033
28. Kariharan T, Nanayakkara G, Parameshwaran K, Bagasrawala I, Ahuja M, Abdel-Rahman E, Amin AT, Dhanasekaran M, Suppiramaniam V, Amin RH (2015) Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression. Neurobiology of aging 36 (3):1451-1461. doi:10.1016/j.neurobiolaging.2014.09.028
29. Thouennon E, Cheng Y, Falahatian V, Cawley NX, Loh YP (2015) Rosiglitazone-activated PPARgamma induces neurotrophic factor-alpha1 transcription contributing to neuroprotection. Journal of neurochemistry 134 (3):463-470. doi:10.1111/jnc.13152
30. Cheng Y, Rodriguiz RM, Murthy SR, Senatorov V, Thouennon E, Cawley NX, Aryal DK, Ahn S, Lecka-Czernik B, Wetsel WC, Loh YP (2015) Neurotrophic factor-alpha1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone. Molecular psychiatry 20 (6):744-754. doi:10.1038/mp.2014.136
31. Nenov MN, Laezza F, Haidacher SJ, Zhao Y, Sadygov RG, Starkey JM, Spratt H, Luxon BA, Dineley KT, Denner L (2014) Cognitive enhancing treatment with a PPARgamma agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice. The Journal of neuroscience : the official journal of the Society for Neuroscience 34 (3):1028-1036. doi:10.1523/JNEUROSCI.3413-13.2014
32. Torres RC, Magalhaes NS, PM ES, Martins MA, Carvalho VF (2016) Activation of PPAR-gamma reduces HPA axis activity in diabetic rats by up-regulating PI3K expression. Experimental and molecular pathology 101 (2):290-301. doi:10.1016/j.yexmp.2016.10.002
33. Villapol S (2018) Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation. Cellular and molecular neurobiology 38 (1):121-132. doi:10.1007/s10571-017-0554-5
34. Beurel E, Toups M, Nemeroff CB (2020) The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron 107 (2):234-256. doi:10.1016/j.neuron.2020.06.002